EGFR and hepatocellular carcinoma: In conclusion, our study revealed the EMX1-EGFR-ERK axis and, for the first time, shed light on the mechanism of EMX1-FL in stimulating HCC metastatic properties, and EMX1-EGFR therefore is a potential target for reducing HCC metastasis.